Lumos Diagnostics Holdings Limited
LDXHF
$0.115
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -27.15% | -27.15% | 127.98% | 127.98% | 53.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -27.15% | -27.15% | 127.98% | 127.98% | 53.54% |
| Cost of Revenue | -20.18% | -20.18% | 66.29% | 66.29% | 34.23% |
| Gross Profit | -31.75% | -31.75% | 178.33% | 178.33% | 69.64% |
| SG&A Expenses | 19.73% | 19.73% | 8.41% | 8.41% | 0.35% |
| Depreciation & Amortization | -12.62% | -12.62% | 3.86% | 3.86% | -21.36% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.92% | 2.92% | 16.41% | 16.41% | 5.35% |
| Operating Income | -126.99% | -126.99% | 38.40% | 38.40% | 54.10% |
| Income Before Tax | -100.96% | -100.96% | 56.28% | 56.28% | 9.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -100.96% | -100.96% | 56.28% | 56.28% | 9.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -100.96% | -100.96% | 56.28% | 56.28% | 9.47% |
| EBIT | -126.99% | -126.99% | 38.40% | 38.40% | 54.10% |
| EBITDA | -155.13% | -188.94% | 51.01% | 51.01% | 56.07% |
| EPS Basic | -26.09% | -26.09% | 68.06% | 68.06% | 50.00% |
| Normalized Basic EPS | -28.57% | -28.57% | 68.89% | 68.89% | 74.55% |
| EPS Diluted | -26.09% | -26.09% | 68.06% | 68.06% | 50.00% |
| Normalized Diluted EPS | -28.57% | -28.57% | 68.89% | 68.89% | 74.55% |
| Average Basic Shares Outstanding | 55.08% | 55.08% | 37.92% | 37.92% | 85.53% |
| Average Diluted Shares Outstanding | 55.08% | 55.08% | 37.92% | 37.92% | 85.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |